The Project Review Committee (PRC) consists of up to 11 members, both academic researchers and relevant companies. The PRC reviews and rates all abstracts as well as non-anonymised full-length applications. They then nominate projects to the Steering Group. Academic PRC members may not apply as main applicants in a Grant Type 1 call round while sitting on the committee.
You can read more about the review organs on our website or contact us for more information.
Mark Denham, AU
Senior Researcher, Department of Molecular Medicine, Aarhus University Hospital; Co-founder, UniPotent Therapeutics
Karen Dybkær Sørensen, AAU
Professor, Department of Clinical Medicine, Aalborg University; Department of Hematology, Aalborg University Hospital
Thomas Emil Andersen, SDU
Professor, Department of Clinical Microbiology
Jørn Bolstad Christensen, KU
Associate Professor, Department of Chemistry
Andrew Urquhart, DTU
Associate Professor, Department of Health Technology
Sebastian Beck Jørgensen, Novo Nordisk
Scientific Director, R&D External Innovation, Scientific Partnerships & Integration
Karina Fog, H. Lundbeck
Senior Director, Biology Lead Protein Aggregation, Folding & Clearance, Neuroscience
Asha Seth, AstraZeneca
Director
ABOUT ODIN
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
CONTACT ODIN
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 116, Bldg 1535-117.
